环氧合酶2及其抑制剂与动脉粥样硬化的研究进展

被引:2
作者
李骊华
雷寒
机构
[1] 重庆医科大学附属第一医院心内科
关键词
环氧合酶-2; 动脉粥样硬化; 环氧合酶-2抑制剂;
D O I
暂无
中图分类号
R543 [血管疾病];
学科分类号
摘要
引用
收藏
页码:2273 / 2275
页数:3
相关论文
共 12 条
[1]   选择性环氧化酶-2抑制剂对载脂蛋白E基因敲除小鼠动脉粥样硬化影响的实验研究 [J].
郭远林 ;
陈纪林 .
中国循环杂志, 2005, (02) :148-151
[2]  
Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?*[J] . Elliot V. Hersh,Edward T. Lally,Paul A. Moore.Current Medical Research and Opinion? . 2005 (8)
[3]  
Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?[J] . J. A. Paramo,J. A. Rodriguez,O. Beloqui,J. Orbe.Current Drug Target -Cardiovascular & Hematologic . 2005 (4)
[4]   Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults [J].
Solomon, DH ;
Schneeweiss, S ;
Glynn, RJ ;
Kiyota, Y ;
Levin, R ;
Mogun, H ;
Avorn, J .
CIRCULATION, 2004, 109 (17) :2068-2073
[5]   Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans [J].
Cipollone, F ;
Fazia, M ;
Iezzi, A ;
Zucchelli, M ;
Pini, B ;
De Cesare, D ;
Ucchino, S ;
Spigonardo, F ;
Bajocchi, G ;
Bei, R ;
Muraro, R ;
Artese, L ;
Piattelli, A ;
Chiarelli, F ;
Cuccurullo, F ;
Mezzetti, A .
CIRCULATION, 2003, 107 (11) :1479-1485
[6]   Selective COX-2 inhibition improves endothelial function in coronary artery disease [J].
Chenevard, R ;
Hürlimann, D ;
Béchir, M ;
Enseleit, F ;
Spieker, L ;
Hermann, M ;
Riesen, W ;
Gay, S ;
Gay, RE ;
Neidhart, M ;
Michel, B ;
Lüscher, TF ;
Noll, G ;
Ruschitzka, F .
CIRCULATION, 2003, 107 (03) :405-409
[7]  
Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association[J] . Thomas A. Pearson,George A. Mensah,R. Wayne Alexander,Jeffrey L. Anderson,Richard O. Cannon,Michael Criqui,Yazid Y. Fadl,Stephen P. Fortmann,Yuling Hong,Gary L. Myers,Nader Rifai,Sidney C. Smith,Kathryn Taubert,Russell P. Tracy,Frank Vinicor.Circulation: Journal
[8]   Cyclooxygenase-2 inhibition and cardiovascular events [J].
Pitt, B ;
Pepine, C ;
Willerson, JT .
CIRCULATION, 2002, 106 (02) :167-169
[9]  
Comparison of thromboembolic events in patients treated with Celecoxib , a Cyclooxygenase-2 specific inhibitor, versus Ibuprofen or Diclofenac[J] . William B White,Gerald Faich,Andrew Whelton,Clement Maurath,Nancy J Ridge,Kenneth M Verburg,G.Steven Geis,James B Lefkowith.The American Journal of Cardiology . 2002 (4)
[10]   Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries [J].
Stemme, V ;
Swedenborg, J ;
Claesson, HE ;
Hansson, GK .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2000, 20 (02) :146-152